BR9303898A - Processo para preparar um conjugado imunogênico de isotiazolonas e veículo macromolecular, para produzir anticorpos monoclonais e para determinar a presença ou concentraçao de isotiazolonas e composiçao compreendendo um hibridoma - Google Patents

Processo para preparar um conjugado imunogênico de isotiazolonas e veículo macromolecular, para produzir anticorpos monoclonais e para determinar a presença ou concentraçao de isotiazolonas e composiçao compreendendo um hibridoma

Info

Publication number
BR9303898A
BR9303898A BR9303898A BR9303898A BR9303898A BR 9303898 A BR9303898 A BR 9303898A BR 9303898 A BR9303898 A BR 9303898A BR 9303898 A BR9303898 A BR 9303898A BR 9303898 A BR9303898 A BR 9303898A
Authority
BR
Brazil
Prior art keywords
isothiazolones
monoclonal antibodies
preparing
hybridoma
concentration
Prior art date
Application number
BR9303898A
Other languages
English (en)
Portuguese (pt)
Inventor
Gary Lewis Willingham
Richard Farrel Schuman
Chun-Hsien Huang
John Steven Chapman
Original Assignee
Rohm & Haas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohm & Haas filed Critical Rohm & Haas
Publication of BR9303898A publication Critical patent/BR9303898A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/815Test for named compound or class of compounds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/141111Diverse hetero atoms in same or different rings [e.g., alkaloids, opiates, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9303898A 1992-09-28 1993-09-24 Processo para preparar um conjugado imunogênico de isotiazolonas e veículo macromolecular, para produzir anticorpos monoclonais e para determinar a presença ou concentraçao de isotiazolonas e composiçao compreendendo um hibridoma BR9303898A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92776592A 1992-09-28 1992-09-28

Publications (1)

Publication Number Publication Date
BR9303898A true BR9303898A (pt) 1994-06-14

Family

ID=25455220

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9303898A BR9303898A (pt) 1992-09-28 1993-09-24 Processo para preparar um conjugado imunogênico de isotiazolonas e veículo macromolecular, para produzir anticorpos monoclonais e para determinar a presença ou concentraçao de isotiazolonas e composiçao compreendendo um hibridoma

Country Status (19)

Country Link
US (1) US5554542A (enExample)
EP (1) EP0592127B1 (enExample)
JP (1) JPH07294522A (enExample)
KR (1) KR940006604A (enExample)
CN (1) CN1090929A (enExample)
AT (1) ATE165009T1 (enExample)
AU (1) AU675802B2 (enExample)
BR (1) BR9303898A (enExample)
CA (1) CA2106693A1 (enExample)
CZ (1) CZ202693A3 (enExample)
DE (1) DE69317976T2 (enExample)
DK (1) DK0592127T3 (enExample)
ES (1) ES2115022T3 (enExample)
HU (1) HU214700B (enExample)
IL (1) IL107055A0 (enExample)
MY (1) MY109450A (enExample)
SG (1) SG81877A1 (enExample)
TW (1) TW258789B (enExample)
ZA (1) ZA937028B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218181B1 (en) 1998-03-18 2001-04-17 The Salk Institute For Biological Studies Retroviral packaging cell line
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
NZ532151A (en) * 2004-04-06 2007-09-28 George William Mason John Brod A method of quantitation of chemical preservatives within wood using enzyme linked immunosorbent assay technology combined with chromatographic analysis
WO2007001192A1 (en) * 2005-06-28 2007-01-04 Matthews, John, Brodie Method of determining biocides within wood
PL1976877T5 (pl) 2005-11-30 2017-09-29 Abbvie Inc Przeciwciała monoklonalne przeciwko białku amyloidu beta oraz ich zastosowania
PT2289909E (pt) 2005-11-30 2015-02-10 Abbvie Inc Método de rastreio, processo de purificação de globulómeros a-beta não difundíveis, anticorpos selectivos contra os referidos globulómeros a-beta não difundíveis e processo para o fabrico dos referidos anticorpos
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
WO2008104386A2 (en) 2007-02-27 2008-09-04 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
CA2796339C (en) 2010-04-15 2020-03-31 Abbott Laboratories Amyloid-beta binding proteins
MX358739B (es) 2010-08-14 2018-09-03 Abbvie Inc Star Proteinas de union a amiloide beta.
US8912003B2 (en) 2011-08-26 2014-12-16 General Electric Company Methods and devices for detecting isothiazolones
EP3856258B1 (en) * 2018-09-27 2024-07-31 Pierre Fabre Medicament Sulfomaleimide-based linkers and corresponding conjugates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456691A (en) * 1983-02-28 1984-06-26 Suad Stark Antigen for PCB, antibody raised by same, and method of making same
US4652530A (en) * 1985-07-15 1987-03-24 Rohm And Haas Company Monitoring method for isothiazolones in aqueous systems
US4865972A (en) * 1986-08-22 1989-09-12 Westinghouse Electric Corp. Antibody-based bioassay for enzyme-inducing chemicals
IL83419A0 (en) * 1986-09-15 1988-01-31 Westinghouse Electric Corp Antibodies reactive with chlorinated phenols,their preparation and their use
GB9017880D0 (en) * 1990-08-15 1990-09-26 Cambridge Innovation Brokers Assay
US5094957A (en) * 1990-12-10 1992-03-10 Rohm And Haas Company Quantitative method for determining concentration of 3-isothiazolone

Also Published As

Publication number Publication date
EP0592127B1 (en) 1998-04-15
AU4752493A (en) 1994-04-14
JPH07294522A (ja) 1995-11-10
HUT67054A (en) 1995-01-30
US5554542A (en) 1996-09-10
KR940006604A (ko) 1994-04-25
AU675802B2 (en) 1997-02-20
CA2106693A1 (en) 1994-03-29
CN1090929A (zh) 1994-08-17
DE69317976D1 (de) 1998-05-20
ZA937028B (en) 1994-03-29
TW258789B (enExample) 1995-10-01
HU9302736D0 (en) 1994-01-28
EP0592127A1 (en) 1994-04-13
IL107055A0 (en) 1993-12-28
ATE165009T1 (de) 1998-05-15
MY109450A (en) 1997-01-31
SG81877A1 (en) 2001-07-24
DK0592127T3 (da) 1999-01-04
DE69317976T2 (de) 1998-11-12
HU214700B (hu) 1998-08-28
CZ202693A3 (en) 1994-04-13
ES2115022T3 (es) 1998-06-16

Similar Documents

Publication Publication Date Title
BR9303898A (pt) Processo para preparar um conjugado imunogênico de isotiazolonas e veículo macromolecular, para produzir anticorpos monoclonais e para determinar a presença ou concentraçao de isotiazolonas e composiçao compreendendo um hibridoma
CA2047717A1 (en) Monoclonal antibodies for small moieties, methods therefor
NL990008I2 (nl) CD#2#5 bindende molekulen.
ATE114479T1 (de) Über thioetherbindungen verknüpfte immunokonjugate, mit verminderter toxizität und vermehrter selektivität.
EP0375422A3 (en) Composition and methods for determining the presence of amphetamines in a sample suspected of containing amphetamine and/or methamphetamine
AU5872790A (en) Oxidative denaturation of protein analytes
EP0257778A3 (en) Apolipoprotein b-specific monoclonal antibodies produced by two novel hybridomas
EP0194158A3 (en) Anti-nicotine and anti-cotinine antibodies (monoclonal and other), and their uses in nicotine and cotinine assays
AU2032988A (en) A genus-specific listeria antigen identified by monoclonal antibodies
PT90296A (pt) Processo para a preparacao de anticorpos monoclonais contra pseudomonas aeruginosa e de composicoes farmaceuticas que os contem
AU8264491A (en) Monoclonal antibodies to leptosphaeria
AU7942791A (en) Monoclonal antibodies to mycosphaerella species
AU8819391A (en) Antibody reactive to hamster immunoglobulins

Legal Events

Date Code Title Description
EE Request for examination
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
FA8 Dismissal: dismissal - article 36, par. 1 of industrial property law